Patents Examined by Amy L. Clark
  • Nutraceutical gels
    Patent number: 10363280
    Abstract: A nutraceutical food product includes a solid matrix and a liquid combined into a gel. The nutraceutical food product may include an immune modulator, such as transfer factor and/or a nanofraction immune modulator. A fruit component may be included in the nutraceutical food product. The fruit component may include at least one oligoproanthocyanidin-containing fruit, such as açai.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: July 30, 2019
    Assignee: 4Life Patents, LLC
    Inventors: Brent M. Vaughan, Calvin W. MacCausland, David A. Lisonbee
  • Topical formulation and uses thereof
    Patent number: 10322155
    Abstract: The present invention provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analog or derivative thereof and (ii) a penetration enhancer, and optionally including tannic acid, or an analog or derivative thereof. The present invention also provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analog or derivative thereof, and (ii) tannic acid, or an analog or derivative thereof, optionally including a penetration enhancer. Also provided are kits and methods of prophylactic or therapeutic treatment of inflammatory and/or degenerative conditions using the combination of active ingredients as herein described.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: June 18, 2019
    Assignee: ARTHRITIS RELIEF PLUS LTD.
    Inventors: Larry McKay, Kanu Patel, Robert John Capon, Kay McKay
  • Methods for treatment of m-TOR inhibitor-associated stomatitis
    Patent number: 10293010
    Abstract: Embodiments of the invention relate to a method for the treatment of mIAS or prevention of symptoms associated with mIAS in a patient in need thereof comprising administering to a patient in need thereof an amount of a composition comprising extracts of the plant species Sambucus nigra, Echinacea purpurea, and Centella asiatica. Optionally the ratio of Sambucus nigra, Echinacea purpurea and Centella asiatica is about 7:1:2. Further embodiments relate to use of extracts of the plant species Sambucus nigra, Echinacea purpurea, and Centella asiatica for the manufacture of a medicament for the treatment of mIAS or prevention of symptoms associated with mIAS in a patient in need thereof.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: May 21, 2019
    Assignee: IZUN PHARMACEUTICALS CORPORATION
    Inventors: William Z. Levine, Gabriel Jay Nussbaum
  • Composition comprising natural substances having healing, repellent and biocidal properties for the treatment and the cure of external wounds
    Patent number: 10293011
    Abstract: Compositions of natural substances for human and veterinary use are provided and include neem oil mixed with the oil extract of Hypericum. The compositions have healing, anti-bacterial, anti-inflammatory, and pain relieving properties combined with a repellent effect against myiasigenic diptera and non-myiasigenic diptera. The compositions can be used for the treatment and the cure of external wounds of any type and extension.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: May 21, 2019
    Assignee: PHYTOCEUTICALS LTD.
    Inventors: Fiorella Carnevali, Stephen Andrew Van Der Esch
  • Compositions comprising non-acidic Boswellia oil fraction as a bio-enhancer for enhancing bioavailability of biological agents
    Patent number: 10286023
    Abstract: The invention relates to a non-acidic Boswellia low polar gum resin extract fraction (BLPRE) in combination with biological agents for enhancing the bioavailability of the biological agents. The invention also provides composition(s) comprising a Boswellia low polar gum resin extract (BLPRE) in combination with a biological agent for increasing the bioavailability of biological agent.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: May 14, 2019
    Assignee: LAILA NUTRACEUTICALS
    Inventors: Ganga Raju Gokaraju, Rama Raju Gokaraju, Venkata Kanaka Ranga Raju Gokaraju, Trimurtulu Golakoti, Kiran Bhupathiraju, Venkata Krishna Raju Alluri
  • Homeopathic complex
    Patent number: 10286074
    Abstract: The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuriz calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: May 14, 2019
    Inventors: Daniel Farrington, Thomas Farrington
  • Skin care formulations
    Patent number: 10285932
    Abstract: Formulations to treat skin discoloration via a multi-modal approach are provided in some embodiments in which select ingredients work together to effectively brighten skin and treat hyperpigmentation. In other embodiments, soothing redness correction formulations are provided. In yet other embodiments, certain formulations are renewal formulations adapted to treat the eye area to, for example, reduce laxity, puffiness, wrinkles and/or dark circles around the eye.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: May 14, 2019
    Assignee: COLORESCIENCE, INC.
    Inventors: Patricia McGill Boland, Deborah Eileen Gregg Bouche, John Anthony Garruto, Bethany Ann McCarver
  • Methods and compositions to reduce fat gain, promote weight loss in animals
    Patent number: 10279003
    Abstract: The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: May 7, 2019
    Inventor: Julius Enyoug Oben
  • Method for obtaining an extract rich in ellagic acid tannins from fruits that contain these compounds, and resulting extract
    Patent number: 10278949
    Abstract: A biotechnology process that employs membrane technology for obtaining an extract rich in tannins of ellagic acid from blackberries (Rubus spp.) and from other fruits that contain these compounds, as well as to the extract obtained using this method. The method is essentially based on baromembrane technologies that allow mechanical separation and effective fractionation between the polyphenol compounds, by interactions between the physico-chemical properties thereof, the material of the membrane and the molar mass of same, thereby allowing enrichment of a fraction of the natural extract with ellagic acid tannins and modification of the content thereof in terms of anthocyanins and other compounds such as sugars and acids.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: May 7, 2019
    Assignees: UNIVERSIDAD DE COSTA RICA, CENTRO INTERNACIONAL DE COOPERACION EN INVESTIGACION AGRICOLA PARA EL DESARROLLO, CIRAD, CENTRO INTERNACIONAL DE ESTUDIOS SUPERIORES EN CIENCIAS AGRONOMICAS, SUPAGRO
    Inventors: Oscar Gerardo Acosta Montoya, Ana Mercedes Perez Carvajal, Manuel Dornier, Fabrice Vaillant
  • Methods and compositions to reduce fat gain, promote weight loss in mammals
    Patent number: 10279001
    Abstract: The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: May 7, 2019
    Inventor: Julius Enyoug Oben
  • Methods and compositions to reduce fat gain, promote weight loss in mammals
    Patent number: 10279002
    Abstract: The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: May 7, 2019
    Inventor: Julius Enyoug Oben
  • Composition for enhancing male sex hormone and men's health
    Patent number: 10245292
    Abstract: The present disclosure relates to a use of a dandelion extract and a Rooibos extract. The present disclosure also relates to a food composition and a pharmaceutical composition for preventing and improving climacteric, including a dandelion extract, or a dandelion and Rooibos composite extract as an active ingredient.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: April 2, 2019
    Assignee: FAMENITY CO., LTD
    Inventors: Do Hee Kim, Yoon Hwa Jeong, Ji Won Lee, Yoo Hun Noh, Ji Ae Park, Seng Ah Lee
  • Synergistic anti-inflammatory compositions comprising extract
    Patent number: 10206964
    Abstract: The present invention discloses synergistic nutraceutical or pharmaceutical or dietary supplement anti-inflammatory compositions comprising therapeutically effective combination of an extract selectively enriched in 3-O-acetyl-1 1-keto-?-boswellic acid (AKBA) derived from Boswellia serrata and Boswellia serrata non-acidic resin extract (BNRE). The composition(s) can be used to prevent, control and treat inflammation and several inflammatory related diseases including asthma, osteoarthritis, rheumatoid arthritis, endothelial dysfunction and the like. The invention further discloses the amelioration of pro-inflammatory biomarker proteins or molecules, whose expression/production is altered during inflammatory diseases.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: February 19, 2019
    Assignee: LAILA NUTRACEUTICALS
    Inventors: Ganga Raju Gokaraju, Rama Raju Gokaraju, Venkata Kanaka Ranga Raju Gokaraju, Trimurtulu Golakoti, Kiran Bhupathiraju, Venkata Krishna Raju Alluri
  • Process for preparing metabolized conditioned growth media
    Patent number: 10206961
    Abstract: Compositions comprising metabolized conditioned growth medium and/or metabolized cell extract and methods of use are described. The metabolized conditioned growth medium and metabolized cell extract compositions may be formulated with an acceptable carrier into injectable or topical formulations, for example, as a cream, lotion or gel, and may be used in cosmeceutical or pharmaceutical applications. The metabolized conditioned growth medium and metabolized cell extract may also be further processed to concentrate or reduce one or more factors or components contained within the metabolized conditioned growth medium or metabolized cell extract. The growth medium may be conditioned by any eukaryotic cell. The metabolized conditioned growth medium and metabolized cell extract may be used to prevent or treat a condition, for example, a skin condition.
    Type: Grant
    Filed: October 7, 2013
    Date of Patent: February 19, 2019
    Assignee: Allergan, Inc.
    Inventors: James Vincent Gruber, Smitha Rao, Rahul Mehta, Sujatha D. Sonti
  • Dandelion processes, compositions and products
    Patent number: 10184029
    Abstract: Dandelion processes, compositions and products are provided. One process is a method of preparing dandelion that utilizes a species of a Taraxacum genus, the process including the steps of extracting and recovering a rubber and a carbohydrate from a dandelion root substantially simultaneously. The process employs a dandelion species that is selected from the group consisting of: Taraxacum officianale, Taraxacum kok-saghyz, a rubber-bearing species of the genus Taraxacum, and a combination of two or more thereof. This Abstract is provided for the sole purpose of complying with the Abstract requirement rules that allow a reader to quickly ascertain the subject matter of the disclosure contained herein. This Abstract is submitted with the explicit understanding that it will not be used to interpret or to limit the scope or the meaning of the claims.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: January 22, 2019
    Assignee: Kultevat, LLC
    Inventors: Daniel Swiger, James Wade
  • Composition with improved bioavailabilty of saponin and method for improving the bioavailability of saponin
    Patent number: 10172900
    Abstract: The present invention relates to a ginseng mixed composition with improved bioavailability of saponin. Further, the present invention relates to a method for improving saponin bioavailability of a subject comprising: administering to the subject an effective amount of at least one extract selected from a Schizandra chinensis extract and a Liriope platyphylla extract that improves saponin bioavailability in the subject.
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: January 8, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hee Young Jeon, Ji Hae Lee, Kyung Mi Joo, Chan Woong Park, Kyung Min Lim, Dae Bang Seo, Sang Jun Lee
  • Wound care product with egg shell membrane
    Patent number: 10166260
    Abstract: A wound care product in the form of a gel is provided, and contains protein from egg shell membrane. The gel is made by first hydrating the egg shell membrane powder and then adding carbomer to partially neutralize the egg shell membrane. The neutralization is completed with the addition of triethanolamine, so as to form a homogeneous gel with a smooth consistency. An antimicrobial compound and a tissue growth accelerator are added to the gel. The gel, infused with egg shell membrane, is applied directly to the wound tissue to form a barrier trapping the active ingredients adjacent the wound site and inhibiting penetration of outside bacteria into the wound site.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: January 1, 2019
    Assignee: Blaine Laboratories, Inc.
    Inventors: Robert C. Blaine, Thang D. Ngo
  • Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
    Patent number: 10159654
    Abstract: Disclosure provides a formulation of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin and to augment the biological activity of curcumin, wherein curcumin is the main constituent of curcuminoid and wherein Ar-turmerone is the main constituent of the essential oil of turmeric. An application of curcuminoid with essential oil of turmeric to enhance the bioavailability of curcumin for oral supplementation against a variety of diseases and method of doing the same is provided.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: December 25, 2018
    Assignee: ARJUNA NATURAL EXTRACTS, LTD
    Inventor: Benny Antony
  • Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes
    Patent number: 10159704
    Abstract: An antifungal liquid composition for topical administration is provided that contains turpentine and at least one of peppermint oil, mineral oil, and essential oil alcohols, and one or more antifungal medications selected from ciclopirox olamine, terbinafine, tolnaftate, microconazole, itraconazole, ketoconazole, econazole, and fluconazole, and optionally one or more antifungal essential oils, and its use in the topical treatment of fungal infection, particularly of the nail.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: December 25, 2018
    Assignee: POWER PHARMACEUTICALS, LLC
    Inventor: Marc Selner
  • Pesticidal plant extract containing loline derivatives
    Patent number: 10149476
    Abstract: This invention relates to a pesticidal compositions containing at least one pyrrolizidine alkaloid compound derived from a plant and endophyte combination, and applying the pesticidal compositions to another plan without pesticidal protection, where upon application of the composition, the plant confers pest protection. The pyrrolizidine alkaloid compound is of Formula (I) wherein: R?H or CH3 and R??H, CH3, CHO, COCH3.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: December 11, 2018
    Assignee: Grasslanz Technology Ltd
    Inventor: Christopher Gerald Lee Pennell